NEO-LARYNGOBIS
TEVA CANADA LIMITED
Quick answers
Is there a shortage of NEO-LARYNGOBIS in Canada?
No. There is no current shortage of NEO-LARYNGOBIS 135MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on fileNone found
Checked by MedShort2026-11-12
DIN
00065927
Strength
135MG
Dosage Form
Suppository
Route
Rectal
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
ACETAMINOPHEN WITH CODEINE - CAPLET
DIN 02143933
ACETAZONE FORTE C8
DIN 00834319
ACT BORTEZOMIB
3.5MG · DIN 02438399
ACT CABERGOLINE
0.5MG · DIN 02301407
ACT CELECOXIB
100MG · DIN 02420155
ACT CELECOXIB
200MG · DIN 02420163
ACT CIPROFLOXACIN
750MG · DIN 02247341
ACT CIPROFLOXACIN
500MG · DIN 02247340
ACT CIPROFLOXACIN
250MG · DIN 02247339
ACT CLOPIDOGREL
75MG · DIN 02303027
ACT DILTIAZEM CD
180MG · DIN 02370638
ACT DILTIAZEM CD
300MG · DIN 02370654